ANGELA HEROUX: Open Payments
NPI 1245078922 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$862 in 48 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $45 · 2025 $862
Food & beverage: $862
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $232 |
| ABBVIE INC. | 13 | $209 |
| Lilly USA, LLC | 5 | $96 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $79 |
| Astellas Pharma US Inc | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| Medtronic, Inc. | 1 | $21 |
Products named: UBRELVY, CAPLYTA, VRAYLAR, Ozempic, QULIPTA, MOUNJARO, Veozah, Wegovy.
Industry payments across NC — which companies pay providers there.
